A detailed history of Wealth Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealth Advisors, Inc. holds 13,115 shares of ABBV stock, worth $2.58 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
13,115
Previous 13,120 0.04%
Holding current value
$2.58 Million
Previous $1.77 Million 10.58%
% of portfolio
0.88%
Previous 0.75%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 23, 2023

SELL
$133.59 - $154.65 $667 - $773
-5 Reduced 0.04%
13,115 $1.95 Million
Q2 2023

Jul 17, 2023

SELL
$132.51 - $164.9 $107,333 - $133,569
-810 Reduced 5.81%
13,120 $1.77 Million
Q1 2023

May 05, 2023

BUY
$144.61 - $166.54 $1.03 Million - $1.18 Million
7,100 Added 103.95%
13,930 $2.22 Million
Q4 2022

Jan 25, 2023

BUY
$138.31 - $165.87 $64,314 - $77,129
465 Added 7.31%
6,830 $0
Q3 2022

Oct 13, 2022

BUY
$134.21 - $153.93 $19,728 - $22,627
147 Added 2.36%
6,365 $854,000
Q2 2022

Aug 05, 2022

BUY
$137.62 - $174.96 $11,009 - $13,996
80 Added 1.3%
6,218 $952,000
Q1 2022

Apr 14, 2022

SELL
$131.98 - $163.75 $3,167 - $3,930
-24 Reduced 0.39%
6,138 $995,000
Q4 2021

Jan 24, 2022

BUY
$107.43 - $135.93 $2,256 - $2,854
21 Added 0.34%
6,162 $834,000
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $57,349 - $65,100
-539 Reduced 8.07%
6,141 $668,000
Q2 2021

Aug 04, 2021

SELL
$105.21 - $117.21 $25,355 - $28,247
-241 Reduced 3.48%
6,680 $792,000
Q1 2021

Apr 28, 2021

SELL
$102.3 - $112.62 $112,427 - $123,769
-1,099 Reduced 13.7%
6,921 $755,000
Q4 2020

Feb 04, 2021

BUY
$80.49 - $108.67 $65,840 - $88,892
818 Added 11.36%
8,020 $859,000
Q3 2020

Oct 19, 2020

BUY
$85.91 - $100.83 $262,197 - $307,733
3,052 Added 73.54%
7,202 $629,000
Q2 2020

Jul 13, 2020

BUY
$73.37 - $98.18 $304,485 - $407,447
4,150 New
4,150 $411,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $348B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wealth Advisors, Inc. Portfolio

Follow Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wealth Advisors, Inc. with notifications on news.